d-alpha tocopherol has been researched along with orlistat in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Koss-Twardy, SG; Melia, AT; Zhi, J | 1 |
| Booth, SL; Calis, KA; McDuffie, JR; Uwaifo, GI; Yanovski, JA | 1 |
| Karatas, F; Kelestimur, H; Ozcelik, O; Ozkan, Y | 1 |
| Henry, L; Mehta, R; Mishra, A; Reyes, MJ; Younossi, ZM | 1 |
| Ganesh, S; Rustgi, VK | 1 |
| Bunjes, H; Roese, E | 1 |
3 review(s) available for d-alpha tocopherol and orlistat
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets.
Topics: Bariatric Surgery; Fatty Liver; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Metabolic Syndrome; Metformin; Non-alcoholic Fatty Liver Disease; Orlistat; Precision Medicine; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E; Weight Loss | 2014 |
Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease.
Topics: Angiotensin Receptor Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Anticholesteremic Agents; Antioxidants; Cannabinoid Receptor Antagonists; Cholagogues and Choleretics; Fatty Acids, Omega-3; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Non-alcoholic Fatty Liver Disease; Orlistat; Pentoxifylline; Piperidines; Probiotics; Pyrazoles; Rimonabant; Synbiotics; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E | 2016 |
2 trial(s) available for d-alpha tocopherol and orlistat
| Article | Year |
|---|---|
The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers.
Topics: Absorption; Adult; Cross-Over Studies; Enzyme Inhibitors; Female; Humans; Lactones; Lipid Metabolism; Lipids; Male; Orlistat; Vitamin A; Vitamin E | 1996 |
Exercise training as an adjunct to orlistat therapy reduces oxidative stress in obese subjects.
Topics: Adult; Anti-Obesity Agents; Antioxidants; Body Composition; Body Weight; Exercise; Female; Humans; Lactones; Lipid Peroxidation; Male; Malondialdehyde; Obesity; Orlistat; Oxidative Stress; Vitamin A; Vitamin E; Weight Loss | 2005 |
3 other study(ies) available for d-alpha tocopherol and orlistat
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of orlistat on fat-soluble vitamins in obese adolescents.
Topics: Adolescent; Analysis of Variance; Avitaminosis; Child; Female; Humans; Lactones; Male; Obesity; Orlistat; Pilot Projects; Prospective Studies; Vitamin A; Vitamin D; Vitamin E | 2002 |
Drug release studies from lipid nanoparticles in physiological media by a new DSC method.
Topics: alpha-Tocopherol; Animals; Blood; Calorimetry, Differential Scanning; Crystallization; Drug Carriers; Drug Liberation; Emulsions; Fenofibrate; Lactones; Nanoparticles; Orlistat; Rapeseed Oil; Swine; Triglycerides; Ubiquinone | 2017 |